Become A Featured Company

Turning Point Brands Announces Second Quarter 2022 Results

Ryan Allway

July 27th, 2022

News, Top News

– Stoker’s continues to gain share with Zig-Zag’s US rolling papers and e-commerce subsegment recording another quarter of double digit growth

 

LOUISVILLE, Ky., July 27, 2022–(BUSINESS WIRE)–Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the second quarter ended June 30, 2022.

 

Q2 2022 vs. Q2 2021

  • Net sales decreased 16.1 percent to $102.9 million
    • Combined net sales for Zig-Zag and Stoker’s Products demonstrated resilience decreasing 0.9 percent for the quarter
    • NewGen net sales declined by 45.1 percent (declined 2.1 percent sequentially)
  • Gross profit decreased 14.2 percent to $51.5 million
  • Net income decreased 64.7 percent to $5.4 million
  • Adjusted EBITDA decreased 17.6 percent to $24.7 million (see Schedule A for a reconciliation to net income)
  • Diluted EPS of $0.30 and Adjusted Diluted EPS of $0.70 as compared to $0.73 and $0.84 in the same period one year ago, respectively (see Schedule B for a reconciliation to Diluted EPS)

“We are pleased with the stable performance of both the Zig-Zag and Stoker’s segments during the quarter in light of a heightened inflationary environment for our customers with rising prices at the pump impacting consumer traffic in convenience stores. While overall sales decreased 16 percent from the previous year, Zig-Zag and Stoker’s sales were steady despite weakness in the wraps and loose leaf subsegments. Zig-Zag maintained its leading positions in both the roll-your-own paper and cigar wraps markets while Stoker’s MST experienced accelerated share gains driven by consumer trade-down to the value category. Despite NewGen revenue decreasing 45 percent from last year, the segment remained relatively stable from the previous quarter and profitable as we continue to monitor FDA regulatory developments,” said Yavor Efremov, President and CEO. “We continued to deploy a substantial amount of our free cash flow towards share repurchases during the quarter while maintaining a strong balance sheet providing us with optionality on further capital deployment.”

 

Mr. Efremov concluded, “Going forward, we maintain a favorable outlook on our underlying business and our competitive positioning. However, given the market environment during the second quarter, along with continued inflationary pressures and resulting uncertainty of consumer confidence, we feel it is prudent to adjust our outlook for the year.”

 

Zig-Zag Products Segment (45 percent of total net sales in the quarter)

For the second quarter, Zig-Zag Products remained broadly in-line with a record performance in 2021 with net sales decreasing 2.1 percent to $46.2 million against a tough comparable period when sales increased 72.3 percent in the prior year period. TPB’s U.S. rolling papers and e-commerce business, and its Canadian business both grew double-digits. However, this was offset by a decline in the cigar wraps business driven partially by a trade inventory reduction during the current period compared against a trade inventory load in the prior year period. Wild Hemp sales moved into the Zig-Zag Products segment during the current year period, which contributed $0.2 million, or 0.4 percent to segment sales. For the second quarter, total Zig-Zag Products segment volume decreased 2.3 percent, while price / mix increased 0.2 percent.

 

For the quarter, the Zig-Zag Products segment gross profit decreased 4.7 percent to $26.4 million. The segment’s gross margin declined 160 basis points to 57.2 percent driven primarily by strong growth in lower gross margin products.

 

“Paper cones and Zig-Zag’s e-commerce business once again drove the growth within our U.S. papers business,” said Graham Purdy, Chief Operating Officer. “Our wraps business saw a double-digit decline due to a tough comparable against a trade inventory load in the prior year period. We are excited to have recently launched distribution of CLIPPER lighters which we expect to ramp up through the second half of the year.”

 

Stoker’s Products Segment (33 percent of total net sales in the quarter)

For the second quarter, Stoker’s Products net sales increased 0.7 percent to $33.6 million. MST grew mid-single digits but was offset by a decline in loose-leaf chewing tobacco. MST represented 65 percent of Stoker’s Products revenues in the quarter, up from 62 percent a year earlier. FRE nicotine pouch products’ sales moved into the Stoker’s Products segment during the current year period and contributed $0.2 million or 0.5 percent to segment sales. For the second quarter, total Stoker’s Products segment volume decreased 6.1 percent, while price / mix increased 6.8 percent.

 

For the quarter, the Stoker’s Products segment gross profit decreased 0.4 percent to $18.1 million. The segment’s gross margin contracted 60 basis points to 53.8 percent due to an inventory write-down of certain FRE products due to rationalization of the product line ahead of the regulatory filing deadline. The segment’s gross margin expanded 80 basis points excluding FRE.

 

“Stoker’s continued to outperform the market with share gains in both the MST and loose-leaf chewing tobacco categories during the quarter,” continued Purdy. “With the current inflationary environment accelerating the secular down-trading trends in the industry, Stoker’s remains well positioned within its categories as a leading value brand.”

 

NewGen Products Segment (22 percent of total net sales in the quarter)

For the second quarter, NewGen Products net sales decreased 45.1 percent to $23.1 million. The regulatory environment for the vape businesses continues to impact sales.

 

For the quarter, the NewGen Products segment gross profit decreased 50.6 percent to $7.0 million. The segment gross margin contracted 340 basis points from the previous year to 30.1 percent due to product mix and the competitive environment.

 

“Despite another challenging quarter further impacted by new regulation around synthetic nicotine products, our vape business remained profitable,” concluded Purdy. “Meanwhile, our distribution capabilities continued to improve through the quarter as we position our business for a post-PMTA environment while our vapor products’ applications remain under FDA review.”

 

Performance Measures in the Second Quarter

Second quarter consolidated selling, general and administrative (“SG&A”) expenses were $33.3 million compared to $35.1 million in the second quarter of 2021.

 

The second quarter SG&A included the following notable items:

  • $0.3 million of restructuring expenses compared to none in the previous year
  • $0.9 million of ERP / CRM scoping expenses and duplicative system costs compared to none in the previous year
  • $1.5 million of stock options, restricted stock and incentive expense compared to $2.8 million in the year-ago period
  • $0.4 million of transaction expenses compared to $0.7 million in the year-ago period
  • $2.0 million of FDA PMTA-related expenses compared to $0.6 million in the year-ago period
  • $1.6 million from the accounting consolidation of Turning Point Brands Canada compared to $1.1 in the year-ago period with the increase driven by the inclusion of a full quarter of the DVW acquisition in the current period

 

Total gross debt as of June 30, 2022 was $422.5 million. The corresponding net debt (total gross debt less cash) at June 30, 2022 was $315.1 million. The Company ended the quarter with total liquidity of $128.8 million, comprised of $107.4 million in cash and $21.4 million of revolving credit facility capacity.

 

During the quarter, the Company spent $8.8 million to repurchase 301,662 shares at an average price of $29.16 per share. The Company also recorded an additional impairment of $6.3 million during the quarter related to its investment in dosist.

 

2022 Outlook

Due to the uncertain macro environment and slower than expected improvement in our NewGen Products segment, the Company now expects the following full-year 2022 results:

  • Zig-Zag Products sales of $193 to $200 million (compared to previous outlook of $193 to $203 million)
  • Stoker’s Products sales of $127 to $133 million
  • Consolidated adjusted EBITDA of $97 to $103 million

 

Earnings Conference Call

As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 8:30 a.m. Eastern on Wednesday, July 27, 2022. Investment community participants should dial in 10 minutes ahead of time using the toll-free number 888-330-2502 (international participants should call 240-789-2713), and follow the audio prompts after typing in the event ID: 6640134. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.

 

Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted diluted EPS and Adjusted Operating Income. A reconciliation of these non-GAAP financial measures accompanies this release.

About Turning Point Brands, Inc.

Turning Point Brands (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag® and Stoker’s® brands, and its emerging brands within the NewGen segment. TPB’s products are available in more than 215,000 retail outlets in North America, and on sites such as www.zigzag.com and www.solacevapor.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the “SEC”) and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to those included it the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995.

Financial Statements Follow:

 

Turning Point Brands, Inc.
Consolidated Statements of Income
(dollars in thousands except share data)
(unaudited)
Three Months Ended June 30,
2022 2021
Net sales $ 102,925 $ 122,643
Cost of sales 51,456 62,670
Gross profit 51,469 59,973
Selling, general, and administrative expenses 33,323 35,094
Operating income 18,146 24,879
Interest expense, net 5,144 5,522
Investment loss (income) 6,227 (110 )
Income before income taxes 6,775 19,467
Income tax expense 1,569 4,424
Consolidated net income 5,206 15,043
Net loss attributable to non-controlling interest (218 ) (312 )
Net income attributable to Turning Point Brands, Inc. $ 5,424 $ 15,355
Basic income per common share:
Net income attributable to Turning Point Brands, Inc. $ 0.30 $ 0.81
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc. $ 0.30 $ 0.73
Weighted average common shares outstanding:
Basic 18,063,259 18,975,522
Diluted 21,443,279 22,489,662
Supplemental disclosures of statements of income information:
Excise tax expense $ 6,141 $ 7,687
FDA fees $ 171 $ 180
Turning Point Brands, Inc.
Consolidated Balance Sheets
(dollars in thousands except share data)
(unaudited)
June 30, December 31,
ASSETS 2022 2021
Current assets:
Cash $ 107,429 $ 128,320
Accounts receivable, net of allowances of $161 in 2022 and $262 in 2021 9,177 6,496
Inventories 115,129 87,607
Other current assets 27,353 26,746
Total current assets 259,088 249,169
Property, plant, and equipment, net 22,376 18,650
Deferred income taxes 2,111 1,363
Right of use assets 13,749 15,053
Deferred financing costs, net 335 388
Goodwill 162,385 162,333
Other intangible assets, net 86,566 87,485
Master Settlement Agreement (MSA) escrow deposits 29,224 31,720
Other assets 28,475 35,399
Total assets $ 604,309 $ 601,560
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 14,436 $ 7,361
Accrued liabilities 34,560 32,937
Other current liabilities 38 38
Total current liabilities 49,034 40,336
Notes payable and long-term debt 415,410 414,172
Lease liabilities 11,934 13,336
Total liabilities 476,378 467,844
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0- – –
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,797,735 issued shares and 17,890,441 outstanding shares at June 30, 2022, and 19,690,884 issued shares and 18,395,476 outstanding shares at December 31, 2021 198 197
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0- – –
Additional paid-in capital 110,563 108,811
Cost of repurchased common stock (1,907,294 shares at June 30, 2022 and 1,295,408 shares at December 31, 2021) (68,287 ) (48,869 )
Accumulated other comprehensive loss (2,064 ) (195 )
Accumulated earnings 85,641 71,460
Non-controlling interest 1,880 2,312
Total stockholders’ equity 127,931 133,716
Total liabilities and stockholders’ equity $ 604,309 $ 601,560
Turning Point Brands, Inc.
Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
Six Months Ended June 30,
2022 2021
Cash flows from operating activities:
Consolidated net income $ 15,977 $ 26,570
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on extinguishment of debt – 5,706
Gain on sale of property, plant, and equipment (8 ) (2 )
Depreciation expense 1,750 1,546
Amortization of other intangible assets 919 954
Amortization of deferred financing costs 1,291 1,251
Deferred income tax (benefit) expense (146 ) 1,027
Stock compensation expense 2,661 4,263
Noncash lease income (6 ) (19 )
Loss (gain) on investments 6,258 (34 )
Changes in operating assets and liabilities:
Accounts receivable (2,673 ) 3,955
Inventories (27,499 ) (12,007 )
Other current assets (598 ) 813
Other assets 624 599
Accounts payable 7,240 1,423
Accrued liabilities and other 1,359 1,370
Net cash provided by operating activities $ 7,149 $ 37,415
Cash flows from investing activities:
Capital expenditures $ (5,694 ) $ (2,170 )
Acquisitions, net of cash acquired – (3,419 )
Payments for investments – (8,657 )
Restricted cash, MSA escrow deposits (10,078 ) (20,147 )
Proceeds on the sale of property, plant and equipment 63 2
Net cash used in investing activities $ (15,709 ) $ (34,391 )
Cash flows from financing activities:
Proceeds from Senior Secured Notes $ – $ 250,000
Payments of 2018 first lien term loan – (130,000 )
Settlement of interest rate swaps – (3,573 )
Payment of dividends (2,181 ) (2,006 )
Payments of financing costs – (6,921 )
Exercise of options 475 886
Redemption of options (155 ) (2,111 )
Redemption of performance restricted stock units (1,228 ) –
Common stock repurchased (19,418 ) (14,086 )
Net cash provided by (used in) financing activities $ (22,507 ) $ 92,189
Net (decrease) increase in cash $ (31,067 ) $ 95,213
Effect of foreign currency translation on cash $ 56 $ 315
Cash, beginning of period:
Unrestricted 128,320 41,765
Restricted 15,155 35,074
Total cash at beginning of period 143,475 76,839
Cash, end of period:
Unrestricted 107,429 157,474
Restricted 5,035 14,893
Total cash at end of period $ 112,464 $ 172,367

 

Non-GAAP Financial Measures

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted diluted EPS, and Adjusted Operating Income. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted diluted EPS, and Adjusted Operating Income are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted diluted EPS and Adjusted Operating Income are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

 

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted diluted EPS” as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Operating Income” as operating income excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.

 

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted EBITDA Adjusted diluted EPS and Adjusted Operating Income exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

 

In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures.

 

Schedule A
Turning Point Brands, Inc.
Reconciliation of GAAP Net Income to Adjusted EBITDA
(dollars in thousands)
(unaudited)
Three Months Ended
June 30,
2022 2021
Net income attributable to Turning Point Brands, Inc. $ 5,424 $ 15,355
Add:
Interest expense, net 5,144 5,522
Income tax expense 1,569 4,424
Depreciation expense 879 758
Amortization expense 456 479
EBITDA $ 13,472 $ 26,538
Components of Adjusted EBITDA
Corporate restructuring (a) 270 –
ERP/CRM (b) 861 –
Stock options, restricted stock, and incentives expense (c) 1,502 2,764
Transactional expenses (d) 364 702
FDA PMTA (e) 1,957 –
Non-cash asset impairment (f) 6,300 –
Adjusted EBITDA $ 24,726 $ 30,004
(a) Represents costs associated with corporate restructuring, including severance.
(b) Represents cost associated with scoping new ERP and CRM systems.
(c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.
(d) Represents the fees incurred for transaction expenses.
(e) Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).
(f) Represents impairment of investment in dosist.
Schedule B
Turning Point Brands
Reconciliation of GAAP diluted EPS to Adjusted diluted EPS
(dollars in thousands except share data)
(unaudited) Three Months Ended
June 30,
2022 2021
GAAP EPS $ 0.30 $ 0.73
Corporate restructuring (a) 0.01 –
ERP/CRM (b) 0.03 –
Stock options, restricted stock, and incentives expense (c) 0.05 0.09
Transactional expenses (d) 0.01 0.02
FDA PMTA (e) 0.07 –
Non-cash asset impairment (f) 0.23 –
Tax (expense) benefit (g) 0.00 (0.01 )
Adjusted diluted EPS $ 0.70 $ 0.84
Totals may not foot due to rounding

 

(a) Represents costs associated with corporate restructuring, including severance, tax effected at the quarterly tax rate.
(b) Represents cost associated with scoping new ERP and CRM systems tax effected at the quarterly tax rate.
(c) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs tax effected at the quarterly tax rate.
(d) Represents the fees incurred for transaction expenses tax effected at the quarterly tax rate.
(e) Represents costs associated with applications related to the FDA PMTA tax effected at the quarterly tax rate.
(f) Represents impairment of investment in dosist tax effected at the quarterly tax rate.
(g) Represents adjustment from quarterly tax rate to annual projected tax rate of 23% in 2022 and 2021.

 

Schedule C
Turning Point Brands, Inc.
Reconciliation of GAAP Operating Income to Adjusted Operating Income
(dollars in thousands)
(unaudited)
Consolidated Zig-Zag Products Stoker’s Products NewGen Products
2nd Quarter 2nd Quarter 2nd Quarter 2nd Quarter 2nd Quarter 2nd Quarter 2nd Quarter 2nd Quarter
2022 2021 2022 2021 2022 2021 2022 2021
Net sales $ 102,925 $ 122,643 $ 46,226 $ 47,202 $ 33,588 $ 33,369 $ 23,111 $ 42,072
Gross profit $ 51,469 $ 59,973 $ 26,430 $ 27,743 $ 18,079 $ 18,146 $ 6,960 $ 14,084
Operating income $ 18,146 $ 24,879 $ 18,503 $ 21,338 $ 13,378 $ 13,826 $ 552 $ 1,657
Adjustments:
Corporate restructuring 270 – – – – – – –
ERP/CRM 861 – – – – – –
Transactional expenses 364 702 – – – – – –
FDA PMTA 1,957 – – – – – – –
Adjusted operating income $ 21,598 $ 25,581 $ 18,503 $ 21,338 $ 13,378 $ 13,826 $ 552 $ 1,657

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005234/en/

 

Contacts

Investor Contacts
Turning Point Brands, Inc.:
Louie Reformina, Senior Vice President, CFO
Turning Point Brands, Inc.
502.774.9238
ir@tpbi.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading